GE HealthCare Technologies Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Peter J. Arduini
- Full Time Employees
- 54,000
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 500 West Monroe Street Chicago IL United States 60661
- IPO Date
- Dec 15, 2022
- CIK
- 0001932393
- Website
- gehealthcare.com
- Similar Companies
- Business
- GE HealthCare Technologies Inc. specializes in the design, production, and global distribution of advanced products, extensive services, and integrated digital platforms aimed at patient diagnostics, therapeutic interventions, and ongoing monitoring across numerous international regions. The organization structures its operations into four distinct divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division delivers sophisticated molecular imaging, computed tomography (CT), magnetic resonance (MR), image-guided therapy, and X-ray systems, alongside specialized offerings for women's health screening. The Ultrasound division offers solutions for the detection, assessment, treatment, and continuous oversight of various conditions through applications in radiology, primary care, cardiovascular health, women’s health, and handheld point-of-care devices, also incorporating surgical visualization and guidance products with AI-enabled productivity tools. The Patient Care Solutions division is dedicated to furnishing medical devices, essential consumables, supportive services, and intelligent digital tools for patient monitoring, anesthesia delivery and respiratory management, diagnostic cardiology, and maternal and infant care. The Pharmaceutical Diagnostics division supplies a range of diagnostic agents, including contrast media for CT, angiography, X-ray, and MR scans, as well as single-photon emission computed tomography and positron emission tomography, to the radiology and nuclear medicine sectors. This segment also provides pharmaceuticals administered prior to imaging to enhance tissue visibility and molecular imaging agents, which are radiopharmaceuticals with radioisotopes used for diagnostic scans. The company was established as a corporate entity in 2022 and maintains its primary corporate offices in Chicago, Illinois. In a significant recent development, the company has agreed to acquire Intelerad, a medical imaging software provider, for $2.3 billion, a move set to substantially enhance its cloud-based and AI-enabled imaging solutions, particularly expanding its reach into outpatient and teleradiology markets. This acquisition is expected to accelerate GE HealthCare's transition to a software-as-a-service (SaaS) business model and significantly boost its recurring revenue.
Company News
GEHC Q3 Earnings Call Highlights Raised Outlook and Margin Risks
GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments
GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments
GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
GEHC vs. HAE: Which Stock Is the Better Value Option?
GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling
GE HealthCare Technologies Q3 Earnings Call Highlights
GE HealthCare Lifts Forecasts on Healthy Hospital Spending
GE HealthCare Technologies Inc. (GEHC) Q3 2026 Earnings Call Transcript
GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View Raised
Compared to Estimates, GE HealthCare (GEHC) Q3 Earnings: A Look at Key Metrics
GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat Estimates
GE HealthCare reports third quarter 2026 financial results
GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?
GEHC Expands Theranostics Imaging With 5 Global Collaborations
GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging
GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
GE HealthCare expands general imaging ultrasound portfolio with LOGIQ Focus, elevating everyday ultrasound performance